Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils
about
sameAs
Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26Natural truncation of the chemokine MIP-1 beta /CCL4 affects receptor specificity but not anti-HIV-1 activityRole of CCL3L1-CCR5 genotypes in the epidemic spread of HIV-1 and evaluation of vaccine efficacy.Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses.Screening effective differential expression genes for hepatic carcinoma with metastasis in the peripheral blood mononuclear cells by RNA-seq.Differential inhibition of human immunodeficiency virus type 1 in peripheral blood mononuclear cells and TZM-bl cells by endotoxin-mediated chemokine and gamma interferon production.Combinatorial content of CCL3L and CCL4L gene copy numbers influence HIV-AIDS susceptibility in Ukrainian children.Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.A CD4+ T cell antagonist epitope down-regulates activating signaling proteins, up-regulates inhibitory signaling proteins and abrogates HIV-specific T cell function.The chemokine system: tuning and shaping by regulation of receptor expression and coupling in polarized responses.Tyrosine Kinase Inhibition Regulates Early Systemic Immune Changes and Modulates the Neuroimmune Response in α-SynucleinopathyAmine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection.RANTES (CCL5) reduces glucose-dependent secretion of glucagon-like peptides 1 and 2 and impairs glucose-induced insulin secretion in mice.Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.High-Content Genome-Wide RNAi Screen Reveals CCR3 as a Key Mediator of Neuronal Cell Death.Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice.Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmissionCopy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease.CCR1 as a target for multiple myeloma.CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.CD26 and Asthma: a Comprehensive Review.Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor.Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis.Indomethacin causes prostaglandin D(2)-like and eotaxin-like selective responses in eosinophils and basophils.Functional expression of CCL8 and its interaction with chemokine receptor CCR3.Cambogin suppresses dextran sulphate sodium-induced colitis by enhancing Treg cell stability and function.Association of the polymorphisms of chemokine genes (IL8, RANTES, MIG, IP10, MCP1 and IL16) with the pathogenesis of autoimmune thyroid diseases.Association of CCL5 and CCR5 gene polymorphisms with periodontitis in Taiwanese.Cordycepin induces apoptosis of human ovarian cancer cells by inhibiting CCL5-mediated Akt/NF-κB signaling pathway.
P2860
Q28072580-CE5C4BEA-DB3D-4B65-AC67-F5F8858CF011Q28205217-35333D5B-4183-4FF9-B8C4-75B8F44A3C67Q33383193-491BAECB-DAE8-44D2-99D1-66497DE61D7BQ33428789-9FEF3CA1-89F9-4934-AB26-79BF5C25FBE0Q33709527-9DF72457-469F-4913-807D-7EAC47AE29B7Q33827798-A3E96202-6947-400D-B743-400D73B62B4DQ34091158-784ADAB0-E48F-4B45-B4B9-A1A45C84A6D0Q34362854-4D7BF9C2-FCFB-4C43-BBC8-D17F043C704CQ34486338-52432761-3C1A-4982-88D7-FC6546A3F179Q34929196-3FB816B5-371F-4669-9C95-9991F609FDBAQ35019131-76FCA5CD-747C-4D06-95E9-CF10A9248555Q35168395-D5669873-1805-426F-AF2F-DCBFA6B48B29Q35175990-256BDA1D-0501-4562-A127-3D1DFC759A97Q35189265-4A565A58-8940-42B4-89A0-86FDA23A8C5CQ36185144-1DC082B6-4404-4679-9E0C-D4DEB1E6CA34Q36404955-F95C6346-3CE8-4546-BF10-3E11A0726953Q36628269-DD158E4B-E8EB-4D5B-8536-B3C9AA8DB34BQ37775691-6BB336FC-8F79-4EFA-9944-01BCA5A0B453Q37879210-F28391A9-4415-456B-8D7B-B7CD28E07F3CQ38690194-29879DDC-97A3-48C0-AD55-253AB097286BQ38937243-22D139EC-2156-406D-A769-B74E2FF754E7Q39882857-67C8596C-F6E5-4FDE-93E8-EFECE782E5FAQ42197506-AE03E6D0-6413-4BAD-8704-CE66E52D9CE6Q43974216-CF3A327D-9F1B-4E8D-9E5A-3FEB89A74186Q47119819-53E1FA25-EEDE-47FB-905F-3AD8575ED06CQ47550996-1895977A-8CDE-44E1-8920-DA01AE218E71Q51728143-DE29C1EF-8BE9-4713-A718-C22532C63809Q54223996-A80E9ED4-689F-4B35-99F7-409D19AC9429Q55062364-7812D720-C955-4D64-918D-14ADFA9A71F2
P2860
Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Diverging binding capacities o ...... or neutrophils and eosinophils
@ast
Diverging binding capacities o ...... or neutrophils and eosinophils
@en
Diverging binding capacities o ...... or neutrophils and eosinophils
@nl
type
label
Diverging binding capacities o ...... or neutrophils and eosinophils
@ast
Diverging binding capacities o ...... or neutrophils and eosinophils
@en
Diverging binding capacities o ...... or neutrophils and eosinophils
@nl
prefLabel
Diverging binding capacities o ...... or neutrophils and eosinophils
@ast
Diverging binding capacities o ...... or neutrophils and eosinophils
@en
Diverging binding capacities o ...... or neutrophils and eosinophils
@nl
P2093
P2860
P50
P921
P3181
P1476
Diverging binding capacities o ...... or neutrophils and eosinophils
@en
P2093
P2860
P304
P3181
P356
10.1002/1521-4141(200107)31:7<2170::AID-IMMU2170>3.0.CO;2-D
P407
P577
2001-07-01T00:00:00Z